Delivery Order 75N93018D00001-75N93022F00007
Award Date
6/1/22
Potential Completion Date
5/31/23
Potential Value
$158K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Sri International
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $451,555 delivery order contract to Sri International under the master indefinite-delivery indefinite-quantity contract titled "Nonclinical Services for Development of Interventional Agents." The contract is for Sri International to provide nonclinical services for the development of interventional agents for infectious diseases from September 1,...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The contract, valued at $452,091.00, is for nonclinical services related to the development of interventional agents for infectious diseases. This award is part of a larger master indefinite delivery/indefinite quantity (IDIQ) contract...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $115,733 firm-fixed-price delivery order contract to Sri International, a non-profit research institute, for nonclinical services to support the development of interventional agents for infectious diseases. The contract has an estimated completion date of April 30, 2024 and is not set aside for any specific business type. Sri International has extensive...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,950,919 delivery order contract to Sri International under the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity master contract. Sri International will provide nonclinical services for the development of interventional agents for infectious diseases with a focus on coronavirus COVID-19. The period of performance is from September 14, 2022...
This is a federal contract award to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The $257,053 delivery order contract is for non-clinical services to support the development of interventional agents for infectious diseases. This award is part of a larger NIAID indefinite delivery vehicle contract for nonclinical services. The...
Sri International has been awarded a $8.96 million delivery order against the Nonclinical Services for Development of Interventional Agents master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The delivery order is for nonclinical services to support the development of interventional agents for infectious diseases. Work will be performed by Sri International in West Menlo Park, California over a one year period concluding in March...
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to SRI International, a non-profit research institute, for $122,706.00. The contract is for nonclinical services to support the development of interventional agents for infectious diseases. It is not associated with a larger contract vehicle and does not have a set-aside designation. SRI International has a history of providing a range...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.3 million delivery order contract to Sri International of West Menlo Park, California under the master indefinite-delivery indefinite-quantity contract titled Nonclinical Services for Development of Interventional Agents. The 24-month cost-plus-fixed-fee contract provides nonclinical services for the development of interventional agents for infectious diseases to support the Department of...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $495,405 delivery order to Sri International under the nonclinical services for development of interventional agents indefinite-delivery/indefinite-quantity master contract. Sri International will perform work on the manufacture of an oligonucleotide modifier in West Menlo Park, California over a period of performance from March 3rd, 2022 through June 30th, 2023. The contract type is cost plus fixed...
This is a $117,119.24 cost-plus-fixed-fee delivery order contract awarded to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the process development and synthesis of 100 grams of ARN0075039, a non-GMP material. It is part of the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award has no...